GlassScriptPhysician profile
Preety Chawla
NPI 1336373018
$7,135.78
in general payments reported to CMS, 2019-2025
17 companies · $802 in 2025
The $802 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $489 · 2021: $511 · 2022: $1,362 · 2023: $1,287 · 2024: $1,521 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,610.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,755.21 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Resonate El Icd Vr |
| Medtronic, INC. | $953.99 | 2021-2024 | Micra, Onyx Frontier, Linq II |
| Novartis Pharmaceuticals Corporation | $848.59 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $500.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $337.28 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $316.44 | 2019-2025 | Lifevest |
| Abbott Laboratories | $310.08 | 2019-2023 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $240.71 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $232.02 | 2020-2022 | |
| Medtronic Vascular, INC. | $195.52 | 2020 | |
| Kestra Medical Technology Services, INC. | $99.71 | 2024-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $85.74 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.55 | 2024 | Jardiance |
| Amgen INC. | $63.59 | 2023-2024 | Repatha |
| Alnylam Pharmaceuticals INC. | $51.57 | 2022-2023 | Amvuttra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $40.05 | 2021 | |
| Gilead Sciences, INC. | $19.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preety Chawla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.